Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213216532> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4213216532 endingPage "864" @default.
- W4213216532 startingPage "857" @default.
- W4213216532 abstract "Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist approved for the treatment of acute migraine headaches. Ubrogepant demonstrated efficacy and safety in 2 pivotal phase 3 studies (N = 2240) that led to its approval. Here, we report the pharmacokinetics and safety results from a phase 1 study in which participants with severe (n = 4), moderate (n = 8), or mild (n = 8) hepatic impairment and matched participants with normal hepatic function (n = 8) were administered a single dose of 100 mg of ubrogepant. Twenty-eight participants aged 36 to 70 years were enrolled and completed the study. In participants with mild, moderate, or severe hepatic impairment, ubrogepant systemic exposure (area under the plasma concentration-time curve) increased by 7%, 52%, and 115%, respectively, compared with participants with normal hepatic function (≈1600 ng • h/mL). Peak exposure increased by 1%, 18%, and 26%, respectively, in participants with mild, moderate, or severe hepatic impairment compared to those with normal hepatic function (≈400 ng/mL). Plasma protein binding did not change significantly across groups. No dose adjustment is recommended for patients with mild or moderate hepatic impairment. Dose adjustment (50 mg) is recommended for patients with severe hepatic impairment. Single doses of ubrogepant 100 mg were safe, and all the enrolled participants, regardless of hepatic function, completed the study." @default.
- W4213216532 created "2022-02-24" @default.
- W4213216532 creator A5018613594 @default.
- W4213216532 creator A5027479348 @default.
- W4213216532 date "2022-02-16" @default.
- W4213216532 modified "2023-10-16" @default.
- W4213216532 title "Single‐Dose Pharmacokinetics and Safety of Ubrogepant in Adults With Hepatic Impairment: Results From an Open‐Label, Phase 1 Trial" @default.
- W4213216532 cites W1930835984 @default.
- W4213216532 cites W2025682604 @default.
- W4213216532 cites W2048132386 @default.
- W4213216532 cites W2062955354 @default.
- W4213216532 cites W2129181629 @default.
- W4213216532 cites W2570330573 @default.
- W4213216532 cites W2770034111 @default.
- W4213216532 cites W2980853513 @default.
- W4213216532 cites W2990037077 @default.
- W4213216532 cites W2994337559 @default.
- W4213216532 cites W2998183969 @default.
- W4213216532 cites W3003253385 @default.
- W4213216532 cites W3005217585 @default.
- W4213216532 cites W3008845344 @default.
- W4213216532 doi "https://doi.org/10.1002/cpdd.1066" @default.
- W4213216532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35174666" @default.
- W4213216532 hasPublicationYear "2022" @default.
- W4213216532 type Work @default.
- W4213216532 citedByCount "0" @default.
- W4213216532 crossrefType "journal-article" @default.
- W4213216532 hasAuthorship W4213216532A5018613594 @default.
- W4213216532 hasAuthorship W4213216532A5027479348 @default.
- W4213216532 hasBestOaLocation W42132165321 @default.
- W4213216532 hasConcept C112705442 @default.
- W4213216532 hasConcept C126322002 @default.
- W4213216532 hasConcept C141071460 @default.
- W4213216532 hasConcept C197934379 @default.
- W4213216532 hasConcept C2780966972 @default.
- W4213216532 hasConcept C71924100 @default.
- W4213216532 hasConcept C90924648 @default.
- W4213216532 hasConceptScore W4213216532C112705442 @default.
- W4213216532 hasConceptScore W4213216532C126322002 @default.
- W4213216532 hasConceptScore W4213216532C141071460 @default.
- W4213216532 hasConceptScore W4213216532C197934379 @default.
- W4213216532 hasConceptScore W4213216532C2780966972 @default.
- W4213216532 hasConceptScore W4213216532C71924100 @default.
- W4213216532 hasConceptScore W4213216532C90924648 @default.
- W4213216532 hasIssue "7" @default.
- W4213216532 hasLocation W42132165321 @default.
- W4213216532 hasLocation W42132165322 @default.
- W4213216532 hasLocation W42132165323 @default.
- W4213216532 hasOpenAccess W4213216532 @default.
- W4213216532 hasPrimaryLocation W42132165321 @default.
- W4213216532 hasRelatedWork W2010519611 @default.
- W4213216532 hasRelatedWork W2012205326 @default.
- W4213216532 hasRelatedWork W2051764329 @default.
- W4213216532 hasRelatedWork W2074207917 @default.
- W4213216532 hasRelatedWork W2087813266 @default.
- W4213216532 hasRelatedWork W2554635175 @default.
- W4213216532 hasRelatedWork W2806504080 @default.
- W4213216532 hasRelatedWork W3003574523 @default.
- W4213216532 hasRelatedWork W3184495456 @default.
- W4213216532 hasRelatedWork W4366822339 @default.
- W4213216532 hasVolume "11" @default.
- W4213216532 isParatext "false" @default.
- W4213216532 isRetracted "false" @default.
- W4213216532 workType "article" @default.